A prospective study comparing Total Lymphocyte Count (TLC) and CD4 counts in HIV patients in a resource limited setting in India
Lincy Lal1★, Cijo George2, Anitha Yesoda3, Jayakumar B4★ Corresponding author
- 1Pharmcoeconomic Research Specialist, Drug Use Policy and Pharmacoeconomics, UT MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 706, Houston, Texas 77030.
- 2Manager-Clinical Pharmacy, HCG Towers, P.Kalinga Rao Road, Bangalore-27, Karnataka, INDIA.
- 3Asso. Professor, College of Pharmaceutical sciences, Medical college, Thiruvananthapuram, Kerala, INDIA.
- 4Prof & Head, Dept. Of Medicine, Medical college Hospital, Thiruvananthapuram, Kerala, INDIA.
CORRESPONDENCE
Lincy Lal
Pharmcoeconomic Research Specialist, Drug Use Policy and Pharmacoeconomics, UT MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 706, Houston, Texas 77030.
Received: 09-09-2008; Revised: 19-09-2008; Accepted: 23-09-2008.
Volume 2, Issue 1 · pp. 28–35 · PUBLISHED · DOI:
ABSTRACT
Even after 25 years of the first detection of Acquired Immunodeficiency Syndrome (AIDS), it remains a major health care problem without any cure. Extensive research around the world and the subsequent introduction of highly active antiretroviral therapy (HAART) has produced dramatic reduction on morbidity, mortality and health care utilization. HAART regimens have revolutionized the treatment of human immunodeficiency virus (HIV), which consistently results in sustained suppression of HIV-1 RNA replication, resulting in gradual increases in CD4 T lymphocyte count, sometimes to normal levels.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Lal, L., George, C., Yesoda, A., & B, J. (). A prospective study comparing Total Lymphocyte Count (TLC) and CD4 counts in HIV patients in a resource limited setting in India. Indian Journal of Pharmacy Practice, 2(1), 28–35.